✦ LIBER ✦

Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.

✍ Scribed by HR Brunner; H Gavras; B Waeber; GA Turini; DN McKinstry; RA Vukovich; I Gavras

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MK-421: A new oral angiotensin convertin

✍ Roger K Ferguson; Peter H. Vlasses; Brian N. Swanson; David J. Cooper; Richard O 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Effects of SQ 14.225, an orally active i

✍ D. Kentera; D. Sušić; A. Cvetković; Gordana Djordjević 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 400 KB

Chronic antihypertensive effects of capt

✍ Bernard Rubin; Michael J. Antonaccio; Morton E. Goldberg; Don N. Harris; Arthur 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 886 KB

Valsartan, a new angiotensin II antagoni

✍ Black, H R; Graff, A; Shute, D; Stoltz, R; Ruff, D; Levine, J; Shi, Y; Mallows, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 272 KB

A single-blind study of doxazosin in the

✍ Rudolf Georg Englert; Herbert Mauersberger 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 717 KB

Clinical experience and rationale for an

✍ James L. Pool; Edward B. Nelson; Addison A. Taylor 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 697 KB